The incidence of Staphylococcus aureus ST8-USA300 among French pediatric inpatients is rising

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 5, 2015, Pages 935-942

  van der Mee Marquet, N ^a   Poisson, D M ^b   Lavigne, J P ^c   Francia, T ^a   Tristan, A ^d   Vandenesch, F ^d   Quentin, R ^a   Bertrand, X ^e  

^a SERVICE DE DERMATOLOGIE   (France)

^b Service d'urologie andrologie   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID; KANAMYCIN; PANTON VALENTINE LEUKOCIDIN; TOBRAMYCIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; FRANCE; GENOTYPE; HUMAN; INCIDENCE; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTILOCUS SEQUENCE TYPING; PREVALENCE; PRIORITY JOURNAL; SKIN ABSCESS; SKIN DEFECT; ADOLESCENT; CHILD; CLASSIFICATION; CROSS INFECTION; EPIDEMIC; FEMALE; GENETIC VARIABILITY; GENETICS; HOSPITAL; HOSPITAL PATIENT; INFANT; ISOLATION AND PURIFICATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; NEWBORN; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS;

ADOLESCENT; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; EXOTOXINS; FEMALE; FRANCE; GENETIC VARIATION; GENOTYPE; HOSPITALS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INPATIENTS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCAL INFECTIONS;

EID: 84928478095     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2308-3     Document Type: Article

References (17)

1. Vandenesch F, Naimi T, Enright MC et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984
2. Chua KYL, Seemann T, Harrison PF et al (2011) The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] Is highly virulent and genetically distinct. PloS One 6:e25887
3. Tristan A, Bes M, Meugnier H et al (2007) Global distribution of Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 13:594–600
4. Diekema DJ, Richter SS, Heilmann KP et al (2014) Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study. Infect Control Hosp Epidemiol 35:285–292
5. Robert J, Tristan A, Cavalié L et al (2011) Panton–Valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008. Antimicrob Agents Chemother 55:1734–1739
6. Rolo J, Miragaia M, Turlej-Rogacka A et al (2012) High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One 7:e34768
7. Fournier S (2013) Épidémie à Staphylococcus aureus résistant à la méticilline (SARM) exprimant la leucocidine de Panton Valentine dans un service de soins de suite et de réadaptation. La lettre du signalement des infections nosocomiales, n°9, Décembre 2013. Available online at: http://www.invs.sante.fr/esin
8. Baud O, Giron S, Aumeran C et al (2014) First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures. Eur J Clin Microbiol Infect Dis 33:1757–1762
9. Comité de l’Antibiogramme de la Société Française de Microbiologie. Communiqué 2013. Paris, France: SFM ed; 2003. Home page at: http://www.sfm-microbiologie.org
10. Jarraud S, Mougel C, Thioulouse J et al (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70:631–641
11. Monecke S, Luedicke C, Slickers P, Ehricht R (2009) Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 28:1159–1165
12. Murchan S, Kaufmann ME, Deplano A et al (2003) Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 41:1574–1585
13. Tristan A, Rasigade JP, Ruizendaal E et al (2012) Rise of CC398 lineage of Staphylococcus aureus among infective endocarditis isolates revealed by two consecutive population-based studies in France. PLoS One 7:e51172
14. Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM (2005) Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 24(7):617–621
15. Thurlow LR, Joshi GS, Clark JR et al (2013) Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 13(1):100–107
16. Haut Conseil de la Santé Publique (2014) Recommandations sur la conduite à tenir lors d’épisodes de cas groupés d’infections cutanées suppuratives liées aux souches de Staphylococcus aureus résistant à la méticilline (SARM Co)
17. Gbaguidi-Haore H, Thouverez M, Couetdic G, Cholley P, Talon D, Bertrand X (2009) Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing meticillin-resistant Staphylococcus aureus in a French university hospital. J Med Microbiol 58(Pt 10):1337–1342